Fusion of high-purity pharmaceutical-grade salmon DNA (PDRN) and patented transdermal cyclic peptide technology, providing bi-directional cellular revitalization, collagen network remodeling, rapid micro-inflammation soothing, and epidermal smoothing.
Scientific Illustration
PDRN Cyclic Peptide Stick - Mechanism & Scientific Evidence
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramPDRN Cyclic Peptide Stick - Mechanism of Action and Transdermal Delivery Pathway
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| Standard INCI Name |
Aqua, Sodium DNA, Acetyl Tetrapeptide-5, Butylene Glycol, 1,2-Hexanediol |
CAS Registry No. |
9007-49-2 / 82830-45-1 |
| Recommended Dosage |
1.0% - 6.0% (Recommended 2.0% - 4.0%) |
Optimal pH Range |
6.0 - 7.5 |
| Thermal Processing |
Add below 40°C during final blending stage |
Solubility & Method |
Fully miscible in aqueous systems and essence bases |
| Appearance & Odor |
Colorless to pale opalescent viscous liquid, odorless |
Patented Tech / IP |
Salmon PDRN (Purity >98%) + Transdermal Cyclic Carrier Peptides |
💡 Compatibility Guidelines & Precautions: Compatible with hyaluronic acid, peptides, and niacinamide; avoid high concentrations of polyvalent metal ions (e.g., Fe3+, Al3+)
📦
Procurement & Compliance Dossier
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 009132-02411-8820 |
Supply Packaging |
1kg/bottle, 5kg/drum, 20kg/sealed container |
| Minimum Order Quantity (MOQ) |
1 kg (In Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store sealed at 2-8°C, protected from light |
Shelf Life |
24 Months |
| R&D Sample Support |
Complimentary 30g trial sample available upon request |
Quality Documentation |
Batch COA, MSDS, TDS, HPLC Purity Certificate |
💡
Product Planning & Marketing Highlights
Core Mechanism · Key Selling Points · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Salmon polydeoxyribonucleotide (PDRN) combined with cyclic peptides acts as an adenosine A2A receptor agonist, initiating salvage pathways to supply nucleotides for cellular repair, reducing pro-inflammatory cytokines (IL-6, TNF-alpha), and boosting fibroblast VEGF and collagen secretion.
🧴 Recommended Product Formats & Categories:
Post-procedure soothing serums, barrier rescue creams, transdermal essence sticks, targeted micro-infusion liquids
📜 Patented Technologies & Scientific Backing:
Patent-pending cyclic peptide delivery carrier for nucleic acid bioactive macromolecules
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
